About 111 inc. - YI
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
YI At a Glance
111, Inc.
No.295 Zuchongzhi Road
Shanghai, Shanghai 201203
| Phone | 86-21-2053-6666 | Revenue | 1.75B | |
| Industry | Medical Distributors | Net Income | -9,235,929.57 | |
| Sector | Distribution Services | Employees | 1,063 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
YI Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.013 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 1.34 |
| Enterprise Value to EBITDA | 468.817 |
| Enterprise Value to Sales | 0.057 |
| Total Debt to Enterprise Value | 0.339 |
YI Efficiency
| Revenue/Employee | 1,643,174.546 |
| Income Per Employee | -8,688.551 |
| Receivables Turnover | 28.065 |
| Total Asset Turnover | 5.014 |
YI Liquidity
| Current Ratio | 1.088 |
| Quick Ratio | 0.57 |
| Cash Ratio | 0.313 |
YI Profitability
| Gross Margin | 5.761 |
| Operating Margin | -0.082 |
| Pretax Margin | -0.179 |
| Net Margin | -0.529 |
| Return on Assets | -2.651 |
| Return on Equity | N/A |
| Return on Total Capital | 13.866 |
| Return on Invested Capital | N/A |
YI Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | -50.869 |
| Total Debt to Total Assets | 10.761 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | -6.438 |